Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer

Gynecologic Oncology

Volumn 102, Issue 2, 2006, Pages 204-209

  E, Choan ^a,b   Quon, Matthew ^b   Gallant, Victor ^a   Samant, Rajiv ^a,b  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Ovarian cancer; Palliation; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NAUSEA; OVARIAN BLEEDING; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION INDUCED EMESIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33745955151     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.11.047     Document Type: Article

References (21)

1. Cancer Statistics 2004. The American Cancer Society Inc.
2. Piccart M.J., Bertelsen K., James K., et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J. Natl. Cancer Inst. 92 9 (2000) 699-708
3. McGuire W.P., Hoskins W.J., Brady M.F., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N. Engl. J. Med. 334 1 (1996) 1-6
4. Parmar M.K., Ledermann J.A., Colombo N., et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 361 9375 (2003) 2099-2106
5. Muggia F.M., Hainsworth J.D., Jeffers S., et al. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J. Clin. Oncol. 15 3 (1997) 987-993
6. Kudelka A.P., Tresukosol D., Edwards C.L., et al. Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma. J. Clin. Oncol. 14 5 (1996) 1552-1557
7. Gordon A.N., Fleagle J.T., Guthrie D., et al. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J. Clin. Oncol. 19 14 (2001) 3312-3322
8. Friedlander M., Millward M.J., Bell D., et al. A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer. Ann. Oncol. 9 12 (1998) 1343-1345
9. Markman M., Hakes T., Reichman B., et al. Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer. J. Cancer Res. Clin. Oncol. 119 1 (1992) 55-57
10. Hodson D.I., and Krepart G.V. Once-monthly radiotherapy for the palliation of pelvic gynecological malignancy. Gynecol. Oncol. 16 (1983) 112-116
11. Adelson M.D., Wharton J.T., Delclos L., et al. Palliative radiotherapy for ovarian cancer. Int. J. Radiat. Oncol. Biol. Phys. 13 (1987) 17-21
12. May L.F., Belinson J.L., and Roland T.A. Palliative benefit of radiation therapy in advanced ovarian cancer. Gynecol. Oncol. 37 (1990) 408-411
13. Davidson S.A., Rubin S.C., Mychalczak B., et al. Limited-field radiotherapy as salvage treatment of localized persistent or recurrent epithelial ovarian cancer. Gynecol. Oncol. 51 (1993) 349-354
14. Corn B.W., Lanciano R.M., Boente M., et al. Recurrent ovarian cancer: effective radiotherapeutic palliation after chemotherapy failure. Cancer 74 (1994) 2979-2983
15. Gelbrum D., Mychalczak B., Almadrones L., et al. Palliative benefit of external beam radiation in the management of platinum refractory epithelial ovarian carcinoma. Gynecol. Oncol. 69 (1998) 36-41
16. Firat A., and Erickson B. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. Gynecol. Oncol. 80 (2001) 213-220
17. Tinger A., Waldron T., Peluso N., et al. Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 1256-1263
18. Fujiwara K., Suzuki S., Yoden E., et al. Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy. Int. J. Gynecol. Cancer 12 (2002) 250-256
19. Cohen Z.R., Suki D., Weinberg J.S., et al. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J. Neurooncol. 66 3 (2004) 313-325
20. Anupol N., Ghamande S., Odunsi K., et al. Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol. Oncol. 85 3 (2002) 487-492
21. Cormio G., Maneo A., Colamaria A., et al. Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases. Gynecol. Oncol. 89 1 (2003) 116-119